LUMC receives a government subsidy of 1.7 million euros for testing ebola vaccine
The Leiden University Medical Centre (LUMC) and from the European Union (EU) a grant of 1.7 million euros to an ebola-vaccine testing.
It comes to a Canadian vaccine that was successfully deployed during the ebola epidemic in West Africa in 2014 and 2015, according to the LUMC. Over the coming five years with more than ten partners in the research work.
“We’re going to figure out how the immune responses that the ebola vaccine is going exactly fits together,” says Tom Ottenhoff, professor of Infectious diseases at the LUMC. “There are, for example, additional immune cells, what type are these and what compounds they make?”
It is further examined, what the most optimal dose of the vaccine, duration of protection and whether it is safe for children.
For the survey, are all a few hundred volunteers vaccinated. With them is also blood. “The immune response of different people differs widely across,” says Mariëlle Haks, a researcher at the department of Infectious diseases.